QHSLab (QHSLab) Debt-to-Asset : 0.99 (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is QHSLab Debt-to-Asset?

QHSLab's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.72 Mil. QHSLab's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. QHSLab's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was $1.73 Mil. QHSLab's debt to asset for the quarter that ended in Mar. 2024 was 0.99.

QHSLab Debt-to-Asset Historical Data

The historical data trend for QHSLab's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QHSLab Debt-to-Asset Chart

QHSLab Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

13.15

2.12

0.59

0.86

1.06

QHSLab Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.88	0.93	0.95	1.06	0.99

Competitive Comparison of QHSLab's Debt-to-Asset

For the Medical Devices subindustry, QHSLab's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QHSLab's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where QHSLab's Debt-to-Asset falls into.

QHSLab Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

QHSLab's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.782	+	0)	/	1.681
	=	1.06

QHSLab's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.718	+	0)	/	1.731
	=	0.99

QHSLab (OTCPK:USAQ) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

QHSLab Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of QHSLab's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

QHSLab (QHSLab) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (OTCPK:USAQ) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407

Website

https://www.qhslab.com

QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. It is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.

Executives

Troy James Grogan	director, 10 percent owner, officer: CEO/Director	5480 N OCEAN DR B1D, SINGER ISLAND FL 33404
Richard J Rubin	director, 10 percent owner, officer: CEO & Chairman	90 JOHN STREET, SUITE 626, NEW YORK NY 10038